Cargando…
Recombinant human erythropoietin improves neurological outcomes in very preterm infants
OBJECTIVE: To evaluate the efficacy and safety of repeated low‐dose human recombinant erythropoietin (rhEPO) in the improvement of neurological outcomes in very preterm infants. METHODS: A total of 800 infants of ≤32‐week gestational age who had been in an intensive care unit within 72 hours after b...
Autores principales: | Song, Juan, Sun, Huiqing, Xu, Falin, Kang, Wenqing, Gao, Liang, Guo, Jiajia, Zhang, Yanhua, Xia, Lei, Wang, Xiaoyang, Zhu, Changlian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084793/ https://www.ncbi.nlm.nih.gov/pubmed/27130143 http://dx.doi.org/10.1002/ana.24677 |
Ejemplares similares
-
Early amplitude-integrated electroencephalography predicts brain injury and neurological outcome in very preterm infants
por: Song, Juan, et al.
Publicado: (2015) -
Effect of early prophylactic low-dose recombinant human erythropoietin on retinopathy of prematurity in very preterm infants
por: Sun, Huiqing, et al.
Publicado: (2020) -
Erythropoietin Improves Poor Outcomes in Preterm Infants with Intraventricular Hemorrhage
por: Song, Juan, et al.
Publicado: (2021) -
Erythropoietin prevents necrotizing enterocolitis in very preterm infants: a randomized controlled trial
por: Wang, Yong, et al.
Publicado: (2020) -
The Impact of Different Degrees of Intraventricular Hemorrhage on Mortality and Neurological Outcomes in Very Preterm Infants: A Prospective Cohort Study
por: Wang, Yong, et al.
Publicado: (2022)